January 2026 exceptional surveillance of depression in adults: treatment and management (NICE guideline NG222)
In January 2026, we reviewed the section on treatment for a new episode of less severe depression.
Surveillance decision
We will not update the recommendations to include intravenous ketamine as a treatment option in this scenario.
This page was last updated: